SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile shares are facing significant volatility following an orbital insertion failure during a Blue Origin launch, where the latest BlueBird satellite was placed into an unsustainable low orbit. The community is actively debating the reliability of Blue Origin as a launch partner compared to SpaceX, while long-term investors are highlighting the company's insurance coverage and the upcoming backlog of satellites as reasons to maintain their bullish thesis.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors react to the news that Greenland has approved the transfer of a majority interest in the Tanbreez project, bringing the company's total ownership to 92.5%. The community is actively discussing the potential for a significant short squeeze given the high short interest, while expressing bullish sentiment on the asset's strategic value for Western supply chains and its potential for a long-term revaluation.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending as investors rally around the company's expanding role in AI infrastructure, specifically its custom ASIC development and optical networking capabilities. Community conversation is heavily focused on the stock's recent price momentum, a major strategic investment from Nvidia, and growing speculation about collaborative chip development with Google.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is currently attracting intense community attention as traders debate the potential for a massive volatility spike fueled by the escalating Iran conflict and the closure of the Strait of Hormuz. Investors are closely monitoring geopolitical tensions, questioning the sustainability of market valuations, and hedging against potential black swan events while navigating the ETF's inherent structural decay.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing high volatility as the community trades on news surrounding a presidential executive order expected to fast-track research for psychedelic therapies, specifically ibogaine. While bulls are anticipating a significant short squeeze due to the stock's small float and high short interest, bears are highlighting risks like potential share dilution and concerns that the news is already priced into the valuation.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi is seeing heightened retail interest and speculation as investors weigh the potential of its large-scale AI energy infrastructure project against concerns over its pre-revenue status and the recent departure of its CEO. Community discussion is currently focused on the company's long-term growth prospects, active searches for anchor tenants, and the volatility triggered by leadership changes and insider trading activity.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Investors in SOXS are expressing intense frustration as the semiconductor sector continues its prolonged rally, fueled by FOMO and AI-driven exuberance despite significant geopolitical tensions in the Middle East. The community is heavily divided, with many trapped in losing short positions and debating whether the recent market climb represents a sustainable trend or an imminent bubble that is ripe for a sharp reversal.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intense bearish sentiment driven by the rapid rise of AI design alternatives and structural fears regarding the long-term viability of its creative SaaS model. While bulls point to pristine financials and aggressive share buybacks as a generational buying opportunity at historic valuation lows, the community remains divided over whether the company is successfully embedding AI into its ecosystem or simply failing to innovate against newer, agile competitors.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently a focal point for investors as it navigates significant manufacturing scaling challenges and high short interest, with community discussion intensely split between those betting on a major turnaround driven by potential AR glasses partnerships and those who view the stock as a consistent underperformer. Sentiment is largely dominated by the debate over whether the company can successfully transition from prototype to high-volume production, with long-term holders actively defending the stock against bearish sentiment while monitoring upcoming production milestones.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is at the center of intense debate as community members weigh recent flight telemetry data and legal maneuverings against the company's progress toward commercial launch. Sentiment remains sharply divided, with some investors highlighting the potential of the air taxi sector and strategic partnerships, while others express skepticism over testing milestones and the stock's recent performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Recommendation of "Moderate Buy" from Analysts

Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are presently covering the company, MarketBeat.com...

Sana Biotechnology (NASDAQ:SANA) Shares Gap Up   - What's Next?

Sana Biotechnology (NASDAQ:SANA) Shares Gap Up - Here's What Happened...

Baillie Gifford & Co. Sells 4,827,438 Shares of Sana Biotechnology, Inc. $SANA

Baillie Gifford & Co. lessened its stake in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 42.2% in the 4th quarter, according to the company in its most recent 13F filing with the...

Citigroup, JPMorgan And 3 Stocks To Watch Heading Into Tuesday

Stock futures mixed, Citigroup and Wells Fargo report earnings, Sana Biotechnology announces collaboration.read more...

<ul class="summary-bullets"><li>Sana expects to seek the U.S. Food and Drug Administration’s clearance to start clinical trials and begin early stage trials for it as early as this year.&nbsp;</li><li>Sana on Monday said that Mayo purchased 7.5 million shares of the company’s common stock at a price of $3.33 per share for gross proceeds of about $25 million under the deal.</li><li>The purchase price under the agreement implies a potential upside of about 4% from the stock's closing price on Monday.</li></ul><p>Shares of Sana Biotechnology, Inc. (SANA) jumped 24% after-hours on Monday after the company announced a strategic collaboration with Mayo Clinic that involves an equity investment by the latter. &nbsp;</p><p>The agreement is aimed at advancing the development of its investigational cell therapy SC451 for type 1 diabetes. The company expects to seek the U.S. Food and Drug Administration’s clearance to start clinical trials and begin early stage trials for it as early as this year.</p><p>Sana’s SC451 is designed to support long-term glucose control without the need for ongoing insulin therapy in type 1 diabetes patients. The agreement with Mayo is aimed at accelerating development, validation, and standardization of protocols and processes for SC451, and supporting safe, scalable, and consistent delivery across diverse clinical environments.</p><h2 class="st-heading-2">Equity Investment in Sana Biotechnology by Mayo</h2><p>Sana on Monday said that Mayo purchased 7.5 million shares of the company’s common stock at a price of $3.33 per share for gross proceeds of about $25 million under the deal. It also noted that Mayo would have the option to make an additional equity investment of $25 million as part of the collaboration.</p><p>The closing of the sale of the initial $25 million worth of shares is expected to occur on or about April 15, Sana said. &nbsp;</p><p>The purchase price under the agreement implies a potential upside of about 4% from the stock's closing price on Monday and nearly 8% from the closing price on Friday.</p><h2 class="st-heading-2">Wall Street Take</h2><p>According to data from Koyfin, eight of the nine analysts covering SANA rate it ‘Buy’ or higher, while one rates it ‘Hold.’ The 12-month average price target on the stock is $8.43, representing a potential upside of about 163% from the stock’s last closing price.</p><h2 class="st-heading-2">How Did Retail Traders React?</h2><p>On Stocktwits, retail sentiment around SANA stock rose from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume increased from ‘low’ to ‘normal’ levels.</p><p><a href="https://stocktwits.com/symbol/SANA">SANA stock</a> has gained 77% over the past 12 months.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/abde-stock-poised-for-best-rally-in-over-a-year-michael-burry/cZJ87RBRIuv">ABDE Stock Poised For Best Rally In Over A Year — What’s Michael Burry Got To Do With It?</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Last week, Baird maintained AYI’s ‘neutral’ rating but cut price target to $320 from $375. (Representative image: Getty Images)

SANA Stock Rallies 24% After Hours — How Much Is Mayo Clinic Investing In The Company?

Sana on Monday inked a strategic collaboration with Mayo Clinic aimed at advancing the development of its investigational cell therapy SC451 for type 1 diabetes.

Equity

Sana on Monday inked a strategic collaboration with Mayo Clinic aimed at advancing the development of its investigational cell therapy SC451 for type 1 diabetes.


Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines

Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines PR Newswire VANCOUVER, BC, April 6, 2026 Issued on behalf...

JPMorgan Chase & Co. Raises Holdings in Sana Biotechnology, Inc. $SANA

JPMorgan Chase & Co. lifted its holdings in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 180.8% during the third quarter, according to the company in its most recent Form 13F filing with...

Sana Biotechnology (NASDAQ:SANA) Trading Down 7.2% - Here's What Happened

Sana Biotechnology (NASDAQ:SANA) Shares Down 7.2% - Here's Why...

Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Recommendation of "Moderate Buy" by Brokerages

Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and s...

Sana Biotechnology (NASDAQ:SANA) Trading Up 7.8% - Here's What Happened

Sana Biotechnology (NASDAQ:SANA) Trading 7.8% Higher - Still a Buy...

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

SANA
Sana Biotechnology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SANA News

SANASana Biotechnology Inc